Consolidation with bortezomib and dexamethasone following risk-adapted melphalan and stem cell transplant in systemic AL amyloidosis. Academic Article uri icon

Overview

publication date

  • June 1, 2011

Research

keywords

  • Boronic Acids
  • Dexamethasone
  • Melphalan
  • Pyrazines
  • Stem Cell Transplantation

Identity

Scopus Document Identifier

  • 79959927379

Digital Object Identifier (DOI)

  • 10.3109/13506129.2011.574354050

PubMed ID

  • 21838462

Additional Document Info

volume

  • 18 Suppl 1